RePORT International Resources

This app allows users to explore and interact with data from the WHO 2024 Global Tuberculosis Report. It is also available on the Apple App Store by searching for 'TB Report'.

This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current landscape and its possible evolution in the future. It identifies six urgently needed solutions to accelerate access and financing and highlights the roles of different stakeholders to support the implementation of these solutions.

The year 2025 marks a critical milestone under the WHO End TB Strategy, providing an opportunity to assess regional progress, highlight persistent gaps and prioritize the actions needed to achieve the TB-related Sustainable Development Goals (SDGs) by 2030. This report presents an overview of the Region’s performance, informed by the latest epidemiological data, policy commitments and innovative interventions implemented by Member States.

This website provides access to the WHO Global Programme on Tuberculosis and Lung Health's series of TB-related reports dating back to 1997. These reports offer valuable insights into global TB trends, epidemiology, and progress toward TB elimination.

World Health Organization (2025). Guidance on evidence generation on new regimens for tuberculosis preventive treatment.

Please refer to the website for detailed information.

Developed by WHO “The purpose of the manual is to provide guidelines and supporting material for sites embarking on STEPS chronic disease risk factor surveillance.” While focus is non-communicable diseases useful information for communicable disease e.g., STEPS instrument.

The TB digital platform offers dashboards displaying global TB data—from overall trends to specific sources like prevalence surveys. It brings together data from all countries and makes it easier to access and understand through clear, user-friendly visuals.

The database provides the most up-to-date information on clinical trials, operational research, and other studies related to TB and MDR-TB.

The 25th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 5 to 9 May 2025. The Committee considered a total of 59 applications, including 31 proposals for the addition of new medicines or medicine classes, 10 proposals for new indications for currently listed medicines, three proposals for the addition of new formulations of currently listed medicines, one proposal for the removal of a currently listed medicine, and 14 other applications relevant to the Model Lists and the WHO AWaRe classification of antibiotics. This report summarizes the evidence considered and the recommendations made by the Expert Committee in updating the WHO Model Lists of Essential Medicines.

The WHO Global Tuberculosis Programme's newsletter for World TB Day 2025, which highlights the theme "Yes! We Can End TB: Commit. Invest. Deliver." The newsletter calls for urgent action to turn global commitments into results, increase funding, and scale up interventions that are proven to be effective, especially for drug-resistant TB. It includes key messages from various global leaders, such as the WHO Director-General, Dr. Tedros, and author John Green, highlighting the need for solidarity and sustained momentum to end TB